logo
logo
AI + EXCLUSIVE DATA

AI analyzes funding data you can't access anywhere else

Our proprietary AI monitors 15,000+ companies and identifies which funded companies need YOUR specific solution right now.

10-25 personalized leads daily • 92% average intent score • Smart feed technology
Start with:
Flexible Plans • $39/mo or $29/mo annual
AI + real-time funding intelligence
Never see duplicates in your feed
INDUSTRY FIRST

Phase Genomics, Inc. announced it raised $1 Million in an initial filing from an offering of $1.4 Million

Nov 22, 2017almost 8 years ago

Amount Raised

$1 Million

Round Type

seed

SeattleScience And EngineeringData And Analytics

Company Information

Company

Phase Genomics

Location

4000 MASON ROAD

Seattle, Washington, United States

About

Phase Genomics applies proprietary ultra-long-range genome sequencing technology to enable genome assembly, microbiome discovery, as well as analysis of genomic integrity and chromosomal aberrations. In addition to a comprehensive portfolio of laboratory and computational services and products, including reagent kits and genomic services, they also offer an industry-leading genome and metagenome assembly and analysis software. Based in Seattle, WA, the company was founded in 2015 by a team of genome scientists, software engineers, and entrepreneurs. The company’s mission is to empower scientists with genomic tools that accelerate breakthrough discoveries.

FundzWatch™ Score

36
Medium Activity
4 total signals

Buyer Intent Analysis

Get personalized insights on buying likelihood

Related People

Sign in to view contact details

Sign in to view contact details